SecSonar.com

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Labcorp Holdings Inc. (LH) is a Medical - Diagnostics & Research company based in US with a market capitalization of $21.5B. Revenue grew 7.3% year-over-year and the company generated $1.2B in free cash flow. This page tracks LH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 60.9K employees · IPO Mar 29, 1990

Valuation

Valuation & price

$250.40 · as of May 17, 2026 · -13.9% vs 52w high

23.9

P/E ratio

Latest-FY diluted EPS

2.50

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$290$266$243Jul 25Dec 25Jul 26Jul 7, 25$257.87Jul 9, 25$259.07Jul 11, 25$249.62Jul 15, 25$245.65Jul 17, 25$247.24Jul 21, 25$243.04Jul 23, 25$250.51Jul 25, 25$264.96Jul 29, 25$261.72Jul 31, 25$260.08Aug 4, 25$263.85Aug 6, 25$260.85Aug 11, 25$267.67Aug 13, 25$272.54Aug 15, 25$270.38Aug 19, 25$275.77Aug 21, 25$276.56Aug 25, 25$276.11Aug 27, 25$279.30Aug 29, 25$277.99Sep 3, 25$273.84Sep 5, 25$278.67Sep 9, 25$278.11Sep 11, 25$279.72Sep 16, 25$274.09Sep 18, 25$277.15Sep 22, 25$278.90Sep 24, 25$279.35Sep 26, 25$280.61Sep 30, 25$287.06Oct 2, 25$279.44Oct 6, 25$275.05Oct 8, 25$277.51Oct 10, 25$277.88Oct 14, 25$279.78Oct 16, 25$283.71Oct 21, 25$284.13Oct 23, 25$284.00Oct 27, 25$275.66Oct 29, 25$248.14Oct 31, 25$253.96Nov 4, 25$252.33Nov 6, 25$246.64Nov 10, 25$261.13Nov 12, 25$266.00Nov 14, 25$266.89Nov 18, 25$259.81Nov 20, 25$261.47Nov 25, 25$269.83Nov 28, 25$268.78Dec 2, 25$265.93Dec 4, 25$261.48Dec 8, 25$259.94Dec 10, 25$261.99Dec 12, 25$264.18Dec 16, 25$258.11Dec 18, 25$252.03Dec 22, 25$255.06Dec 24, 25$254.46Dec 29, 25$252.97Jan 2, 26$251.66Jan 6, 26$260.40Jan 8, 26$254.67Jan 12, 26$250.39Jan 14, 26$262.00Jan 16, 26$270.87Jan 21, 26$269.14Jan 23, 26$266.66Jan 27, 26$271.12Jan 29, 26$269.81Feb 2, 26$270.29Feb 4, 26$276.16Feb 9, 26$274.01Feb 11, 26$289.89Feb 13, 26$282.63Feb 18, 26$278.76Feb 20, 26$282.67Feb 24, 26$287.13Feb 26, 26$287.62Mar 2, 26$286.47Mar 4, 26$280.85Mar 6, 26$269.67Mar 10, 26$268.70Mar 12, 26$262.91Mar 17, 26$270.62Mar 19, 26$264.09Mar 23, 26$264.42Mar 25, 26$266.02Mar 27, 26$264.20Mar 31, 26$266.81Apr 2, 26$273.72Apr 7, 26$269.17Apr 9, 26$273.26Apr 13, 26$264.18Apr 15, 26$266.73Apr 17, 26$270.68Apr 22, 26$272.62Apr 24, 26$263.80Apr 28, 26$259.57Apr 30, 26$256.80May 4, 26$253.01May 6, 26$256.93May 8, 26$254.12May 12, 26$257.35May 14, 26$254.02May 18, 26$255.57May 20, 26$257.42May 22, 26$259.93May 28, 26$262.75Jun 1, 26$256.87Jun 3, 26$258.92Jun 5, 26$265.15Jun 9, 26$271.24Jun 11, 26$265.27Jun 15, 26$265.03Jun 17, 26$259.56Jun 22, 26$254.43Jun 24, 26$265.18Jun 26, 26$271.47Jul 2, 26$286.98
$243.0452-week range$290.93
Loading valuation history…

Fundamentals

Key fundamentals

$21.5B

Market cap

7.3%

Revenue growth (YoY)

26.8%

Gross margin

$1.2B

Free cash flow (USD)

$6.7B

Net debt

-0.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$9.6BFY 2017$10.4BFY 2018$11.3BFY 2019$11.6BFY 2020$14.0BFY 2021$13.1BFY 2022$11.9BFY 2023$12.2BFY 2024$13.0BFY 2025$14.0B
$9.6B$14B

Free cash flow by year

2016 → 2025

FY 2016$897.0MFY 2017$1.1BFY 2018$925.6MFY 2019$1.0BFY 2020$1.8BFY 2021$2.6BFY 2022$1.5BFY 2023$874.1MFY 2024$1.1BFY 2025$1.2B
$897M$1.2B

Gross margin by year

2021 → 2025

FY 202138.0%FY 202231.3%FY 202327.7%FY 202427.9%FY 202526.8%
38.0%26.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 4, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseJun 30, 2026Filing
  • Insider sellInsider Sell $201K · 10b5-1 PlanKyle Kathryn W · EVP, Chief Legal Officer · $201.1KJun 10, 2026Filing
  • 8-K eventConference Presentation AnnouncementMay 27, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 26, 2026Filing
  • Insider sellInsider Sell $1.5M · 10b5-1 PlanSchechter Adam H · Director, President & CEO · $1.5MMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 4, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • 8-K eventDividend DeclaredApr 9, 2026Filing

Questions

Frequently asked questions

What is Labcorp Holdings Inc.'s market cap?

Labcorp Holdings Inc. (LH) has a market capitalization of $21.5B.

What is LH's P/E ratio?

LH trades at a price-to-earnings ratio of 23.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is LH's price-to-book (P/B) ratio?

LH trades at 2.50 times book value per share.

Are insiders buying LH stock?

SEC Form 4 filings show no open-market insider buys at Labcorp Holdings Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Diagnostics & Research

DGX

Quest Diagnostics Incorporated

$21.6B

MTD

Mettler-Toledo International Inc.

$23.8B

ILMN

Illumina, Inc.

$25B

WAT

Waters Corporation

$25B

GH

Guardant Health, Inc.

$17.2B

MEDP

Medpace Holdings, Inc.

$12.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.